Zevra Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 02/14/2025 | 4.14 M | $34.52 M | 2.25% | 8.66% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.08 M | $34.03 M | 30.71% | 8.53% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.65 M | $30.44 M | 462.40% | 7.63% |
| VANGUARD GROUP INC | 02/11/2025 | 2.82 M | $23.55 M | 2.47% | 5.91% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.34 M | $19.52 M | -19.96% | 4.90% |
| FMR LLC | 02/13/2025 | 2.33 M | $19.43 M | 0.70% | 4.87% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 1.85 M | $15.43 M | 8.82% | 3.87% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.23 M | $10.22 M | 0.07% | 2.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.19 M | $9.91 M | 13.82% | 2.49% |
| STATE STREET CORP | 02/14/2025 | 1.17 M | $9.78 M | 51.72% | 2.45% |
| J. GOLDMAN & CO LP | 02/14/2025 | 875,815 | $7.30 M | -11.01% | 1.83% |
| AIGH CAPITAL MANAGEMENT LLC | 02/12/2025 | 788,614 | $6.58 M | 100.00% | 1.65% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 616,123 | $5.14 M | 2,980.62% | 1.29% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 597,700 | $4.98 M | -14.61% | 1.25% |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 02/10/2025 | 514,832 | $4.29 M | 3.07% | 1.08% |
| UBS GROUP AG | 02/14/2025 | 343,818 | $2.87 M | 1,624.78% | 0.72% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 335,840 | $2.80 M | -19.78% | 0.70% |
| MYSTIC ASSET MANAGEMENT, INC. | 02/10/2025 | 313,347 | $2.61 M | 1.92% | 0.66% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 300,000 | $2.50 M | 50.00% | 0.63% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 292,772 | $2.44 M | 100.00% | 0.61% |
| BARCLAYS PLC | 02/13/2025 | 289,688 | $2.42 M | 402.94% | 0.61% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 249,935 | $2.08 M | 98.62% | 0.52% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 233,132 | $1.94 M | 138.17% | 0.49% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 179,874 | $1.50 M | 0.00% | 0.38% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 153,077 | $1.28 M | -32.61% | 0.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 149,504 | $1.25 M | 23.19% | 0.31% |
| KOVACK ADVISORS, INC. | 02/05/2025 | 146,158 | $1.22 M | -1.78% | 0.31% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 120,000 | $1.00 M | 0.00% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 108,487 | $904,778 | -25.62% | 0.23% |
| CREDIT AGRICOLE S A | 02/14/2025 | 106,000 | $884,040 | 0.00% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 104,630 | $872,614 | -51.29% | 0.22% |
| LMR PARTNERS LLP | 02/14/2025 | 100,000 | $834,000 | 100.00% | 0.21% |
| J. GOLDMAN & CO LP | 02/14/2025 | 97,500 | $813,150 | 2,767.65% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 92,200 | $768,948 | 36.19% | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 85,818 | $715,722 | 100.00% | 0.18% |
| ARETE WEALTH ADVISORS, LLC | 02/12/2025 | 77,972 | $649,000 | 0.00% | 0.16% |
| RHUMBLINE ADVISERS | 01/30/2025 | 68,053 | $567,550 | 18.39% | 0.14% |
| READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 66,662 | $555,961 | 100.00% | 0.14% |
| CITIGROUP INC | 02/12/2025 | 51,284 | $427,709 | 67.97% | 0.11% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 50,906 | $424,556 | 25.38% | 0.11% |
| 02/14/2025 | 42,081 | $350,956 | 100.00% | 0.09% | |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 32,802 | $273,569 | 43.45% | 0.07% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 30,427 | $254,000 | 0.00% | 0.06% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 29,949 | $249,775 | 29.81% | 0.06% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 29,701 | $247,707 | 65.40% | 0.06% |
| IFG ADVISORS, LLC | 02/05/2025 | 29,050 | $242,277 | 10.04% | 0.06% |
| 01/31/2025 | 27,924 | $223,950 | 0.00% | 0.06% | |
| JPMORGAN CHASE & CO | 02/12/2025 | 27,490 | $229,267 | 50.51% | 0.06% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 26,916 | $224,479 | 100.00% | 0.06% |
| ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 26,450 | $220,593 | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zevra Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 123 institutional investors and hedge funds held shares of Zevra Therapeutics, Inc.. The most heavily invested institutionals were:
Woodline Partners LP: 4.14 M
BlackRock Funding, Inc. /DE: 4.08 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.65 M
VANGUARD GROUP INC: 2.82 M
Nantahala Capital Management, LLC: 2.34 M
FMR LLC: 2.33 M
70.89% of Zevra Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 35.98 M shares in the last 24 months. This purchase volume represents approximately $303.69 M in transactions.